<h4>Background</h4>Renal cell carcinoma with sarcomatoid dedifferentiation represents a rare histological entity characterized by aggressive behavior, limited efficacy of tyrosine kinase inhibitors or mTOR inhibitors, and poor outcome. This evidence concerns the gene MTOR and renal cell carcinoma.